Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07798232
PHASE3
Penicillin to Prevent Early Rheumatic Heart Disease in School-Aged Children
Sponsor: Children's Hospital Medical Center, Cincinnati
View on ClinicalTrials.gov
Summary
This study will look at whether children ages 5-8 who take Penicillin V by mouth twice a day are less likely to develop rheumatic heart disease (RHD) over a 3-year period compared to children who do not take the medicine.
Key Details
Gender
All
Age Range
5 Years - 8 Years
Study Type
INTERVENTIONAL
Enrollment
9622
Start Date
2027-02-01
Completion Date
2032-03-01
Last Updated
2026-09-03
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Oral Penicillin V
Twice-daily oral Pen V 250 mg
Locations (1)
Uganda Heart Institute
Kampala, Uganda, Uganda